Page last updated: 2024-10-19

inositol and HIV

inositol has been researched along with HIV in 3 studies

Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research Excerpts

ExcerptRelevanceReference
"The monosaccharide substances inositol hexasulfate (IHS) and inositol hexaphosphoric acid (Phytic acid, IHP) were investigated for their antiviral effect on the human immunodeficiency virus (HIV) in vitro."7.67[Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro]. ( Kanai, M; Kunita, N; Kurimura, T; Miyano, K; Otake, T; Shimonaka, H; Ueba, N, 1989)
"The monosaccharide substances inositol hexasulfate (IHS) and inositol hexaphosphoric acid (Phytic acid, IHP) were investigated for their antiviral effect on the human immunodeficiency virus (HIV) in vitro."3.67[Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro]. ( Kanai, M; Kunita, N; Kurimura, T; Miyano, K; Otake, T; Shimonaka, H; Ueba, N, 1989)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gongvatana, A1
Harezlak, J1
Buchthal, S1
Daar, E1
Schifitto, G1
Campbell, T1
Taylor, M1
Singer, E1
Algers, J1
Zhong, J1
Brown, M1
McMahon, D1
So, YT1
Mi, D1
Heaton, R1
Robertson, K1
Yiannoutsos, C1
Cohen, RA1
Navia, B1
Lentz, MR1
Kim, WK1
Kim, H1
Soulas, C1
Lee, V1
Venna, N1
Halpern, EF1
Rosenberg, ES1
Williams, K1
González, RG1
Otake, T1
Shimonaka, H1
Kanai, M1
Miyano, K1
Ueba, N1
Kunita, N1
Kurimura, T1

Other Studies

3 other studies available for inositol and HIV

ArticleYear
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Journal of neurovirology, 2013, Volume: 19, Issue:3

    Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid;

2013
Alterations in brain metabolism during the first year of HIV infection.
    Journal of neurovirology, 2011, Volume: 17, Issue:3

    Topics: Adult; Anti-Retroviral Agents; Aspartic Acid; Basal Ganglia; Choline; Frontal Lobe; GPI-Linked Prote

2011
[Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1989, Volume: 63, Issue:7

    Topics: Antiviral Agents; HIV; HTLV-I Infections; Humans; Inositol; Monocytes; Phytic Acid

1989